GSE182150 KIT LSD1 MYC inhibition 4 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE182150_KIT_LSD1_MYC inhibition_4_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE182150_KIT_LSD1_MYC inhibition_4_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE182150_KIT_LSD1_MYC inhibition_4_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE182150_KIT_LSD1_MYC inhibition_4_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

GNAS complex locus

Gene

delta like non-canonical Notch ligand 1

Gene

cell division cycle 20

Gene

serpin family A member 1

Gene

brain abundant membrane attached signal protein 1

Gene

PRAME nuclear receptor transcriptional regulator

Gene

neuritin 1

Gene

sushi repeat containing protein X-linked

Gene

vascular endothelial growth factor A

Gene

creatine kinase B

  • Gene

    GNAS complex locus


  • Gene

    delta like non-canonical Notch ligand 1


  • Gene

    cell division cycle 20


  • Gene

    serpin family A member 1


  • Gene

    brain abundant membrane attached signal protein 1


  • Gene

    PRAME nuclear receptor transcriptional regulator



  • Gene

    sushi repeat containing protein X-linked


  • Gene

    vascular endothelial growth factor A


  • Gene

    creatine kinase B

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.